Patents by Inventor Jeffrey L. Dage

Jeffrey L. Dage has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREVENTION OF AXONAL DAMAGE USING ANTIBODY BINDING TO AMYLOID BETA 1-42
    Publication number: 20230287092
    Abstract: The present invention relates to the prevention of neuronal axonal damage. More particularly, the present invention relates to the prevention neuronal axonal damage using binding members that selectively bind human amyloid beta 1-42 peptide (A?1-42), wherein the treatment of a patient with said binding member decreases the level of neurofilament light chain (NfL) in patients.
    Type: Application
    Filed: June 25, 2021
    Publication date: September 14, 2023
    Inventors: Keith Tan, Craig Shering, John R. Sims, Jeffrey L. Dage
  • COMPOUNDS AND METHODS TARGETING HUMAN TAU
    Publication number: 20220146535
    Abstract: The present invention provides compounds and methods targeting human tau, particularly human tau phosphorylated at threonine 217 and isoforms of tau expressed only in the CNS, including therapeutic antibodies, pharmaceutical compositions and diagnostic applications useful in the field of neurodegenerative diseases such as AD, PSP and FTD.
    Type: Application
    Filed: November 24, 2021
    Publication date: May 12, 2022
    Inventors: Xiyun CHAI, Jinbiao CHEN, Jeffrey L. Dage, David Albert Driver, Steven Fisher Hinton, Robert William Siegel, II, Peter Edward Vaillancourt